论文信息 - A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts). - 字舞流文

A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts).

H. Scher | E. Small | D. Danila | C. Ryan | G. Attard | A. Molina | T. Kheoh | A. Reid | E. Thompson | J. de-Bono